This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Spruce Biosciences has swept away 55% of its employees. The biotech took the act...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Transplanting bacteria from the feces of healthy people into the guts of mice an...
Overview of comments received on guideline on clinical investigation of medicina...
Clinical investigation of medicinal products in the treatment of epileptic disor...
Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-r...
As an unplanned overall survival analysis of ivonescimab’s Keytruda head-to-head...
As an unplanned overall survival analysis of ivonescimab’s Keytruda head-to-head...
Agenda - Extraordinary Management Board meeting: 28 April 2025
A closely watched clinical trial testing what could be the world’s first new tub...
Pharmaceutical companies are turning to integrated RWD approaches to overcome ch...
“Confounded by a confusing expression or dream from a patient, I might seemingly...
While physician-scientists are supported in splitting their time between researc...
A close look at Chris Klomp's path to the top of Medicare, which pays for the he...
Device companies already enjoy big profit margins and are finding ways to avoid ...
As Congress returns to work, STAT is tracking what health spending will get cut ...
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab,...
Pharmaceutical group says deal will help it establish leadership in rare tumours
After months of discussion, Germany's Merck KGaA said it would buy SpringWorks T...